Back to Search

ALEXANDER BOTTINI, MD

MD

Retina Specialist (Ophthalmology) Physician

NPI: 1033505086IndividualAccepts Medicare

Specialties, Licenses & Credentials

Ophthalmology Physician

Ophthalmology

Code: 207W00000X

2019014155(MO)
Retina Specialist (Ophthalmology) PhysicianPrimary

Ophthalmology — Retina Specialist

Code: 207WX0107X

2019014155(MO)87920(GA)

CMS Specialties

PrimaryOPHTHALMOLOGY

Education

EMORY UNIVERSITY SCHOOL OF MEDICINE

Class of 2015

Research & Publications (20)

Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex.
PMID 19285133·Neurobiol Dis·2009
8-other
The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib.
PMID 19417138·Cancer Res·2009
8-other
Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients.
PMID 19188178·Clin Cancer Res·2009
8-other
Food for thought... on the economics of animal testing.
PMID 19326029·ALTEX·2009
7-preclinical
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
PMID 19064988·J Clin Oncol·2009
3-trial
Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases.
PMID 18506177·Br J Cancer·2008
2-rct
Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questions.
PMID 18997125·Oncologist·2008
6-review
Retrospective evaluation of clinical outcomes in patients with HER2-positive advanced breast cancer progressing on trastuzumab-based therapy in the pre-lapatinib era.
PMID 18952558·Clin Breast Cancer·2008
4-observational
Optimisation of the post-validation process: the report and recommendations of ECVAM Workshop 67.
PMID 18662098·Altern Lab Anim·2008
7-preclinical
Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.
PMID 18451231·Clin Cancer Res·2008
2-rct

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
1255 FRIENDSHIP RD STE 160
BRASELTON, GA 30517

Quick Facts

NPI
1033505086
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
3
Locations
1
Years in Practice
11
Publications
20

Are you this provider?

Claim Your Profile